We came across a bullish thesis on Medifast (MED) on Value Degen’s Substack by Unemployed Value Degen. In this article we will summarize the bulls’ thesis on MED. Medifast, Inc. share was trading at $18.51 as of Sept 6.
michaeljung/Shutterstock.com
Medifast (MED) was once a key player in the $7 billion structured weight loss program market, with revenues of $1.6 billion and net income of $143 million in 2022. However, the company’s fortunes have declined sharply amid a new medical weight...
